EUVIMEDEUVIMED entdecken
Crossref

Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice

M.A. Krasavina

Practical oncology · 30.03.2026 · v. 27 (1) · 39-51

DOI: 10.31917/2701039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical oncology, online erschienen am 30.03.2026. Verfasst von M.A. Krasavina.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

immune checkpoint inhibitors, antibody-drug conjugates, targeted therapy, circulating tumor DNA, precision medicine, artificial intelligence in oncology.

Zitieren

APA

Krasavina, M. (2026). Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice. Practical oncology, v. 27(1), 39-51. https://doi.org/10.31917/2701039

Vancouver

Krasavina M. Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice. Practical oncology. 2026;v. 27(1):39-51. doi:10.31917/2701039

BibTeX
@article{Krasavina2026,
  author = {Krasavina, M.A.},
  title = {Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice},
  journal = {Practical oncology},
  year = {2026},
  volume = {v. 27},
  number = {1},
  pages = {39--51},
  doi = {10.31917/2701039}
}
Kostenlos starten →